← FDA DRUG APPROVALS

FDA ANDA · ANDA062870

CEPHALEXIN

Sponsor: STEVENS J

APPLICATION
ANDA062870
TYPE
ANDA
ORIGINAL APPROVAL
1988-03-17
LATEST ACTION
1989-03-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEPHALEXINDiscontinued
CEPHALEXIN EQ 250MG BASE · CAPSULE · ORAL

Approval history

1989-03-22Manufacturing (CMC) · Supplement 5AP
1989-01-27Manufacturing (CMC) · Supplement 3AP
1989-01-27Manufacturing (CMC) · Supplement 4AP
1988-04-28Manufacturing (CMC) · Supplement 2AP
1988-04-14Manufacturing (CMC) · Supplement 1AP
1988-03-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →